More successful therapy of hematologic disorders including malignancies requires increased information concerning the processes involved in normal hematopoietic differentiation. A major long-term goal of this work is to understand the critical early events in normal human hematopoiesis which occur as a cell """"""""decides"""""""" between self-renewal and lineage committment and as a cell matures along a lineage pathway. Direct experiments in this area require purified hematopoietic progenitor cells, and therefore would be enabled by a comprehensive battery of monoclonal antibodies recognizing antigens expressed specifically on early hematopoietic cell types. The epitope detected by the anti-My-10 monoclonal antibody is expressed specifically on human marrow blast cells, including essentially all measured hematopoietic progenitor cells. In part I of this project, monospecific rabbit antisera will be prepared against the purified My-10 glycoprotein, in order to determine whether expression of the entire My-10 glycoprotein is restricted to early hematopoietic developmental stages. Additional monoclonal antibodies against the My-10 glycoprotein will also be produced, to allow improved labelling and isolation of My-10- positive marrow progenitor cells. Methods for affinity purification of My-10-positive cells will be tested, as feasibility studies prior to a clinical trial of the use of purified My-10- positive """"""""stem cells"""""""" for clinical bone marrow transplantation with a reduced risk of Graft versus Host Disease. Novel specific anti-human hematopoietic progenitor cell monoclonal antibodies will also be generated in this project and will be used in analysis and isolation of hematopoietic progenitor cells. The second major specific goal of this project is the use of these and other available monoclonal antibodies, with flow cytometry, to construct detailed """"""""maps"""""""" of normal hematopoietic cellular development. These maps will be used to investigate the cellular events in normal versus abnormal myeloid cell.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA032318-04A2
Application #
3170296
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1982-05-01
Project End
1990-04-30
Budget Start
1987-05-01
Budget End
1988-04-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Hurwitz, C A; Gore, S D; Stone, K D et al. (1992) Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. Leukemia 6:233-9
Strauss, L C; Trischmann, T M; Rowley, S D et al. (1991) Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am J Pediatr Hematol Oncol 13:217-21
Gore, S D; Kastan, M B; Civin, C I (1991) Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 77:1681-90
Gore, S D; Kastan, M B; Goodman, S N et al. (1990) Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry. J Immunol Methods 132:275-86
Hurwitz, C A; Strauss, L C; Civin, C I (1990) Immunodiagnosis of acute nonlymphocytic leukemia. Immunol Ser 53:265-87
Civin, C I (1990) Human monomyeloid cell membrane antigens. Exp Hematol 18:461-7
Civin, C I; Strauss, L C; Fackler, M J et al. (1990) Positive stem cell selection--basic science. Prog Clin Biol Res 333:387-401;discussion 402
Fackler, M J; Civin, C I; Sutherland, D R et al. (1990) Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells. J Biol Chem 265:11056-61
Kastan, M B; Schlaffer, E; Russo, J E et al. (1990) Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 75:1947-50
Sharkis, S J; Jones, R J; Bellis, M L et al. (1990) The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors. Blood 76:716-20

Showing the most recent 10 out of 34 publications